DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 2983--------------------------------------------------
       Higher severe COVID-19 risk for patients on Ocrevus, Rituxan
       By: agate Date: July 31, 2020, 11:47 am
       ---------------------------------------------------------
       From MS Focus (July 24, 2020)--"Higher severe COVID-19 risk for
       patients on Ocrevus, Rituxan." The article quotes Dr. Ben
       Thrower, well known in MS research, as saying that the risk of
       taking MS disease-modifying therapy (DMT) still outweighs the
       benefits, however.
  HTML https://msfocus.org/About-Us/MSF-News-Articles/2279
       #Post#: 3278--------------------------------------------------
       (Abst.) COVID-19 in ocrelizumab-treated people w/MS
       By: agate Date: May 4, 2021, 1:46 am
       ---------------------------------------------------------
       Might this be a drug company's response to the reports about a
       higher risk for severe COVID-19 in patients on Ocrevus?  From
       PubMed, "COVID-19 in ocrelizumab-treated people with multiple
       sclerosis" (April 2021):
  HTML https://pubmed.ncbi.nlm.nih.gov/33482590/
       *****************************************************